UBS has downgraded SRF Ltd. shares from 'Buy' to 'Sell', citing ongoing growth challenges and weak demand in the agrochemical sector, particularly with China expected to increase its market share. The price target has been reduced from ₹2,700 to ₹2,100, indicating a potential downside of 9%. Additionally, EPS estimates for FY25 and FY26 have been cut by 20% and 22%, respectively, as the US refrigerant gas market faces weak demand and competitive pressure from Chinese manufacturers.